Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03232021

Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations

Status
Withdrawn
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Saint Savvas Anticancer Hospital · Academic / Other
Sex
All
Age
45 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess the effect of pregabalin administration on catheter-related bladder discomfort (CRBD). The study group includes patients that are about to be subjected to orthopedic operations.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo oral capsulePlacebo oral capsule administered 1 hour prior to the surgical operation
DRUGPregabalin Oral Capsule [Lyrica] 75mgPregabalin Oral Capsule \[Lyrica\] 75 mg administered 1 hour prior to the surgical operation
DRUGPregabalin Oral Capsule [Lyrica] 150 mgPregabalin Oral Capsule \[Lyrica\] 150 mg administered 1 hour prior to the surgical operation

Timeline

Start date
2017-08-16
Primary completion
2018-12-31
Completion
2019-04-30
First posted
2017-07-27
Last updated
2020-03-31

Locations

2 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT03232021. Inclusion in this directory is not an endorsement.